Atg5 — Atg5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ATG5 Protein | |
|---|---|
| Protein Name | ATG5 Protein |
| Gene | ATG5 |
| UniProt ID | Q9H1Y4 |
| PDB IDs | 2L10, 2L11 |
| Molecular Weight | 32 kDa |
| Subcellular Localization | Cytoplasm, Autophagosome |
| Protein Family | ATG (Autophagy-related) family |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease |
ATG5 (Autophagy Related 5) is a protein encoded by a gene located on chromosome 6q21. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. ATG5 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
ATG5 is a 284-amino acid protein with an N-terminal ubiquitin-like domain and a C-terminal alpha-helical region. The protein contains the ATG12 conjugation site (Lys149) and interfaces with ATG16L1 through its C-terminal region. ATG5 forms a stable 1:1 conjugate with ATG12 through an isopeptide bond between Gly186 of ATG12 and Lys149 of ATG5. The ATG12-ATG5 complex dimerizes to create the functional ATG16L1 binding platform.
ATG5 is a key ubiquitin-like protein essential for autophagosome formation. ATG5 undergoes conjugation with ATG12 (via E1-like enzyme ATG7 and E2-like enzyme ATG10) to form the ATG12-ATG5 conjugate. This conjugate then interacts with ATG16L1 to form the ATG16L1 complex, which localizes to the developing phagophore (isolation membrane) and serves as the E3 ligase for LC3 (MAP1LC3A) lipidation. The lipidation of LC3 promotes membrane expansion and closure. In neurons, ATG5-mediated autophagy is crucial for synaptic plasticity, neuronal development, and clearance of misfolded proteins and damaged organelles. Deficiencies contribute to neurodegenerative disease pathogenesis through impaired protein homeostasis.
Alzheimer's Disease, Parkinson's Disease, Huntington's Disease are associated with dysregulation of ATG5. Altered expression or function contributes to disease pathogenesis through various mechanisms including impaired protein homeostasis, calcium dysregulation, and synaptic dysfunction.
Therapeutic targeting of ATG5 for neurodegeneration:
The study of Atg5 — Atg5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.